Insilico, WuXi AppTec unveil one piece of hit-generating AI pipeline

Insilico and WuXi AppTec's Nature Biotechnology study provides initial proof-of-concept for the AI company's de novo small molecule generation platform, but the companies have not yet revealed their methods for taking on orphan targets with no known crystal structures or ligands, one of

Read the full 436 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE